PNEUMONIA and Metoprolol


PNEUMONIA Symptoms and Causes

Pneumonia is an infection in one or both of the lungs. Many germs, such as bacteria, viruses, and fungi, can cause Pneumonia. You can also get Pneumonia by inhaling a liquid or chemical. People most at risk are older than 65 or younger than 2 years of age, or already have health problems.

Symptoms of Pneumonia vary from mild to severe. See your doctor promptly if you

  • Have a high fever
  • Have shaking chills
  • Have a cough with phlegm that doesn't improve or gets worse
  • Develop shortness of breath with normal daily activities
  • Have chest pain when you breathe or cough
  • Feel suddenly worse after a cold or the flu

Your doctor will use your medical history, a physical exam, and lab tests to diagnose Pneumonia. Treatment depends on what kind you have. If bacteria are the cause, antibiotics should help. If you have viral Pneumonia, your doctor may prescribe an antiviral medicine to treat it.

Preventing Pneumonia is always better than treating it. Vaccines are available to prevent pneumococcal Pneumonia and the flu. Other preventive measures include washing your hands frequently and not smoking.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for PNEUMONIA

PNEUMONIA treatment research studies

Metoprolol clinical trials, surveys and public health registries

Find Drug Side Effect reports

Metoprolol Side Effects

Bradycardia (410)
Dizziness (389)
Hypotension (291)
Blood Pressure Increased (282)
Dyspnoea (271)
Fatigue (258)
Completed Suicide (244)
Syncope (220)
Nausea (195)
Headache (188)
Chest Pain (166)
Palpitations (160)
Asthenia (152)
Diarrhoea (151)
Atrial Fibrillation (147)
Hypertension (145)
Pain (140)
Heart Rate Increased (131)
Anxiety (131)
Myocardial Infarction (129)
Fall (115)
Pain In Extremity (111)
Malaise (110)
Toxicity To Various Agents (104)
Oedema Peripheral (102)
Pruritus (101)
Product Substitution Issue (101)
Product Quality Issue (99)
Heart Rate Decreased (96)
Insomnia (96)
Cerebrovascular Accident (96)
Cardiac Arrest (89)
Rash (89)
Vomiting (87)
Feeling Abnormal (86)
Renal Failure (83)
Renal Failure Acute (83)
Depression (83)
Confusional State (78)
Blood Pressure Decreased (77)
Arthralgia (76)
Death (73)
Chest Discomfort (73)
Tachycardia (71)
Loss Of Consciousness (69)
Somnolence (69)
Hyperhidrosis (65)
Cardiogenic Shock (63)
Condition Aggravated (63)
Weight Decreased (62)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

<strong>I was put on Metoprolol ER 2 years ago after having cancer. I was </strong><span style='text-decoration: underline;'>tired all day could not sleep at night, had anxiety attacks, co

I have been taking Toprol XL 100 for 7 yrs with no issues or changes in my EKGs. I was switched to the Generic Metoprolol 50mg twice a day 3 months ago. I started experiencing PVCs and stomach trouble. Went to the ER twice becaus

i've been on the generic metoprolol for 3 days. dr. started me on 25mg 2x per day and i've been experiencing shortness of breath, chest discomfort and dizziness. i cut the dosage down to 6.5mg per day and feel a little better (palpations&

<strong>Tired all the time. Sleep poorly. Dry hacking cough and I am cold all the time. I can't seem to keep warm. I doubleup on my clothing and socks.</strong> <strong>Honestly, I have never

Can i take Acetaminophen W/Codeine #3 with Metoprolol er succinate 25 mg ?

Does anyone have a nagging cough while taking metaprolol?

Does it hurt in your legs real bad, you can't sleep and your chest hurts? See your Doctor.


Evil drug. Side effects in order are, coughing, extreme lethargy, horrible dreams like ones where demons are torturing me that leave me with night terror as I wake up that takes a few minutes to go away, blurred vision, reduced sex drive, horrible he

Fatigue was the biggest problem while taking Metoprolol. It was so bad that when I would come home from work I had to go straight to bed.I also had severe joint pains associated with this medication. I have since changed to Toprol XL, which has made

I am sorry you are in pain. But did you not just say you have Pneumonia!? I think that life threatening infection is worse than the diarrhea dont you?

I just wanted to share that on Sunday night I had a very horrible experience with Delsyn brand cough syrup. I had vivid and terrifying hallucinations after taking it. I am not on other meds except anti-biotics for pneumonia and only t

Background: 55 yr old female, never sick exc for rare cold. No meds (perhaps 10 NSAIDS per year for hormonally related headache). Got the flu before my flu shot kicked ok, my flu turned to pneumonia. Can't take PCNs. No other allergies or

Extreme muscle pain in legs, shoulders, neck and back. already had fibromyalgia and this was worse than any pain had previous to taking simvastatin. I was on it a yr. I had chonic insomnia, chest pain like pneumonia, so tired couldn't hardly move. co

Had been taking coversyl 10mg for a couple of years Had flu like symptoms for last 3 months with dry cough, then got chest pain/shortness of breath. Hospitalised pneumonia in both lungs, a PE and the pain was from pleurisy. Stopped coversyl after see

Hi am a nursing student and my pt has pneumonia and pleural effusion and empyema withlarge abcessand the hostpital is giving him perfalgan is that wrong?

I am a 95yr old male with Age related macular degeneration,the worst diagnosis,sight is extremely limited,hard of hearing,and prone to frequent bouts of recurring pneumonia,in the winter,and usually have ended up in hospital.Other than that I have s

I am a pediatric RN. My son was put on Omnicef after being given Rocephin (1.5gm) for pneumonia. He has been on it before for other things, and each time we've had the same two problems. Extreme sleepiness, and severe aggitation. Yelling, r

I am currently taking Azithromycin - 5 day dose.. started Friday, 8/20 for pneumonia, Sunday shortly after dinner the diarrhea started - HOLY COW.. talk about immense pain anddiscomfort!! Thesame happened Monday night after dinner

I had a ct scan that showed I have an pneumonia I did X-ray and it was negative no pneumonia

PNEUMONIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Operational Research Management for Children With Severe Pneumonia
Condition: Pneumonia
Interventions: Other: Amoxycilline, Cephradine followed by follow up on day 3;   Other: Injectable ampicillin followed by urgent referral
Outcome Measures: Proportion of Severe Pneumonia cases approapriately treated as per the Modified IMCI guideline;   Proportion of severe Pneumonia cases complied appropriately with followup advice given by the health care providers;   Proportion of childhood Pneumonia cases treated by trained service provider
2 Not yet recruiting Safety, Tolerability, and Efficacy Study of Prophylactic Streptococcus Pneumoniae Vaccine Following Challenge With S. Pneumoniae
Conditions: Pneumococcal Infections;   Streptococcus Pneumoniae;   Pneumonia, Pneumococcal
Interventions: Biological: GEN-004 with Aluminum Hydroxide Adjuvant;   Biological: Placebo
Outcome Measures: Efficacy of GEN-003 as measured by reduction in nasopharyngeal colonization;   Evaluation of the safety and tolerability of GEN-004 with aluminum hydroxide as measured by frequency and severity of Adverse Events;   Evaluation of the duration of S. Pneumoniae colonization through 14 days after inoculation;   Evaluation of the immunogenicity of GEN-004 with aluminum hydroxide, as measured by TH17 (IL-17) and IgG responses to the antigens.
3 Unknown  Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
Conditions: Viral Pneumonia;   Bacterial Pneumonia
Outcome Measures: TREM-1 level in the BAL fluid of patients with pure viral Pneumonia in comparison to patients with viral with co-existing bacterial Pneumonia;   TREM-1 level in the BAL fluid of patients with pure bacterial Pneumonia and no Pneumonia;   TREM-1 level in the serum of all 4 groups;   Length of ventilator support, length of ICU and hospital stay
4 Unknown  Microbiology and Clinical Outcome of Pneumonia
Condition: Pneumonia
Outcome Measure: Success/favorable clinical response after treatment for Pneumonia
5 Unknown  Zinc as Adjunct to Treatment of Pneumonia
Condition: Pneumonia
Intervention: Dietary Supplement: Zinc sulphate
Outcome Measures: Time (hours) to resolution of clinical signs of Pneumonia;   Time (hours) to resolution of clinical signs of Pneumonia by type of associated pathiogens ( bacterial/viral)
6 Recruiting Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal Vaccine
Condition: Community Acquired Pneumonia
Interventions: Behavioral: BPS;   Behavioral: Guideline
Outcome Measures: Use of Antibiotics in Each Group;   Treatment Failure in Each Group
7 Not yet recruiting The Effectiveness of Co-packaging With Zinc to Improve Treatment of Diarrhea and Pneumonia in Guatemala
Conditions: Diarrhea.;   Pneumonia.
Intervention: Behavioral: Co-packaging and counseling messages
Outcome Measures: Percentage of caregivers who administer zinc to child for at least 8 days.;   Percentage of caregivers who report giving zinc to child for at least 8 days.;   Improved Provision of Care for Treatment of Diarrhea and Pneumonia
8 Unknown  Prevention of Post-operative Pneumonia (POPP)
Conditions: Post-operative Pneumonia;   Lung Cancer;   Esophageal Cancer
Intervention: Procedure: Intensive Brushing Regimen
Outcome Measures: Incidence of postoperative Pneumonia in the two groups: lung cancer resection patients and esophageal resection patients;   Compliance with preoperative brushing and mouthwash protocol
9 Recruiting Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Conditions: Pneumonia, Bacterial;   Pneumonia, Viral;   Meningitis, Bacterial
Outcome Measures: Incidence of pneumococcal Pneumonia requiring hospitalisation, confirmed by blood culture or PCR analysis of blood;   Incidence of pneumococcal meningitis, confirmed by culture or PCR on cerebro-spinal fluid;   Incidence of radiologically confirmed Pneumonia requiring hospitalisation;   Incidence of suspected Pneumonia requiring hospitalisation with elevated C-reactive protein serum concentration (<40mg/l);   Incidence of suspected Pneumonia requiring hospitalisation with reduced oxygen saturation (<90%);   Incidence of Pneumonia of other bacterial or viral etiology requiring hospitalisation;   Incidence of acute meningitis of other bacterial etiology
10 Unknown  Usefulness of Microbiological Tests in Community-Acquired Pneumonia
Condition: Community-Acquired Pneumonia
Intervention: Procedure: empirical versus microbiological guided treatment
Outcome Measures: Clinical and economic consequences obtained with the antibiotic selection in basis to early mcrobiological results;   Importance of polimicrobial etiology in community-acquired Pneumonia;   Practice usefulness of urinary antigen detection tests in Pneumonia
11 Unknown  Flu Vaccine Against Childhood Pneumonia, Bangladesh
Conditions: Pneumonia;   Laboratory Confirmed Influenza
Intervention: Biological: Trivalent inactivated influenza vaccine
Outcome Measures: Clinical Pneumonia;   Laboratory confirmed influenza infection;   Indirect effects;   Epidemiological and clinical characteristics of influenza infection;   Effect on non-influenza viral and bacterial invasive disease;   Immunogenicity;   Adverse events associated with the vaccine
12 Unknown  Impact of a Multidimensional Intervention in Elderly Patients With Pneumonia
Conditions: Community Acquired Pneumonia;   Healthcare-Associated Pneumonia
Intervention: Other: Multidimensional intervention
Outcome Measures: Healthcare resources utilization (readmissions and consultations to hospital and emergency department).;   Functional status;   Institutionalization;   Survival
13 Not yet recruiting Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia
Condition: Nosocomial Pneumonia
Interventions: Drug: ceftolozane/tazobactam;   Drug: Meropenem
Outcome Measures: All Cause Mortality;   Clinical response rates of ceftolozane/tazobactam versus meropenem in adult subjects with VNP.;   Clinical response rates at the Late Follow-up (LFU) visit for ceftolozane/tazobactam versus meropenem in adult subjects with VNP.;   Per-pathogen microbiological response rates of ceftolozane/tazobactam versus meropenem at TOC.;   Microbiological response rates of ceftolozane/tazobactam versus meropenem at EOT;   Clinical response rates at the TOC visit (ceftolozane/tazobactam versus meropenem) in the subset of subjects who had P. aeruginosa from the baseline lower respiratory tract culture;   Day 14 all-cause mortality rates of subjects in the ceftolozane/tazobactam versus meropenem arms;   Safety will be evaluated in the safety population by presenting summaries of deaths, AEs, laboratory evaluations, vital signs and physical exam in the 2 treatment groups;   Pharmacokinetic parameters, such as maximum concentration achieved (Cmax), total exposure during one dosing interval (AUC0-τ), steady-state volume of distribution (Vss) and Clearance (CLss);   Day 28 all-cause mortality rates of subjects in the ceftolozane/tazobactam versus meropenem arms in the Microbiological Intent-to-Treat (mITT) population;   Clinical response rates at the TOC visit (ceftolozane/tazobactam versus meropenem) in the subset of subjects who had Enterobacteriaceae isolated from the baseline lower respiratory tract culture;   Per-pathogen clinical response at TOC by baseline minimum inhibitory concentration (MIC) and Kirby-Bauer zone diameter for ceftolozane/tazobactam versus meropenem
14 Unknown  Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU Patients
Condition: Ventilator Associated Pneumonia
Interventions: Device: Taper Guard Endotracheal Tube;   Other: Conventional endotracheal tube
Outcome Measures: incidence of ventilator associated Pneumonia(VAP);   Number of days on the ventilator by the time patient is discharged from ICU or hospital or at time of death;   The total number of days spent in the intensive care unit by the time of discharge from hospital or death;   The number of days spent in the hospital by the time of discharge or death;   number of deaths in each arm
15 Recruiting A Randomized Controlled Trial of Lung Ultrasound Compared to Chest X-ray for Diagnosing Pneumonia in the Emergency Department
Condition: Pneumonia
Interventions: Other: Lung Ultrasound;   Radiation: Chest X-Ray
Outcome Measures: Overall reduction of CXR needed to diagnose Pneumonia;   Comparison of unscheduled healthcare visits after the index Emergency Department visit between those subjects who undergo CXR first and those who undergo LUS first.;   Evaluation of the rate of antibiotic use between the two groups.;   Comparison of the admission rates.;   Comparison of the length of stay in the Emergency Department between the two groups.
16 Recruiting Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke
Conditions: Ventilator-associated Pneumonia;   Ischemic Stroke
Interventions: Drug: Atorvastatin;   Drug: Placebo
Outcome Measures: Cumulative frequency of ventilator-associated Pneumonia;   Mortality;   Ventilation free days;   Antibiotic free days;   Whether the bacteria of multidrug-resistance can be isolated from the sputum culture;   Adverse effects
17 Recruiting Duration of Antibiotic Therapy in Community - Acquired Pneumonia
Conditions: Pneumonia;   BronchoPneumonia;   PleuroPneumonia;   Pneumonia, Bacterial;   Pneumonia, Viral
Intervention: Other: Discontinuation of antibiotic therapy
Outcome Measures: Composite outcome including adverse events;   Composite outcome of other adverse events;   Antibiotic exposure;   Adverse effects;   Composite outcome of other adverse events at 90 days;   Length of hospitalization;   Costs
18 Unknown  Effectiveness of H1N1 Influenza Vaccines in Manitoba, Canada
Conditions: Influenza;   Pneumonia
Outcome Measures: Hospitalization with laboratory-confirmed influenza or Pneumonia;   Hospitalization with influenza or Pneumonia
19 Recruiting Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia
Condition: Nosocomial Pneumonia
Interventions: Drug: C Group;   Drug: E Group
Outcome Measures: Extension of the Piperacillin / tazobactam infusion time effect evaluation;   Reducing antibiotic resistance
20 Recruiting Pharmacokinetics of Moxifloxacin in Patients With Pneumonia
Condition: Pneumonia
Outcome Measure: The concentration of Moxifloxacin in blood-plasma